Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407

Overview: Join us as we review the risks and benefits of contraceptive options, focusing on levonorgestrel intrauterine devices (IUDs) and their potential link to breast cancer risk. Hear the data and key considerations to help patients make informed decisions, balancing benefits and risks effectively in your primary care practice.

Episode resource links:

• Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024. doi:10.1001/jama.2024.18575
• https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share

Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406

Overview: An increasing number of therapies are being formulated for nasal delivery. This episode reviews the use of 3 of these therapies: at-home flu vaccines, epinephrine for allergic reactions, and saline nasal sprays for the common cold. Hear how these newly available treatments can increase options for care in your clinical practice.

Episode resource links:

• Flu Vaccine: Vaccine. 2015 Jul 31;33(32):3894-9. doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25.
• Nasal Saline: https://k4.ersnet.org/prod/v2/Front/Program?e=549
• Nasal Epinephrine: https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405

Overview: Explore the American Heart Association’s (AHA) newly validated risk calculator, designed to assess the likelihood of cardiovascular disease and heart failure in patients aged 30-79 years. Hear which risk factors are included, why they matter, and how this tool can enhance your preventive care strategies in primary care practice.

Episode resource links:

• Hypertension. 2024;81:00–00. DOI: 10.1161/HYPERTENSIONAHA.124.22998.)
• https://doi.org/10.1161/CIRCULATIONAHA.123.067626
• The calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com